शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
DSFCLNSEDCM SHRIRAM FINE CHEM LTD· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 14 Aug, 2026 · 13:52 IST

Q1 FY27 results: profit down 42%, revenue dips 8%; new MD appointed

Revenue declinedResults restatedResults View source PDFExplain this filing

DSFCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.4%Reaction day
₹25.14
prior close
₹25.01
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+0.4% vs market
Specialty Chemicals peers, median of 94sector-0.2%+0.6% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
-0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.4+0.1+0.4-0.2+0.6
Next day
+1.4+0.2+1.2-1.1+2.6
2d
+3.5+0.6+2.9-0.9+4.3
3d
+5.5-0.0+5.5-1.2+6.7
4d
+7.6+0.5+7.1-1.3+8.9
5d
+9.8+0.8+9.0-1.0+10.8
1w
+7.4+0.6+6.8-1.0+8.4
15d
+2.9+1.3+1.7+0.6+2.3
1m
-2.3-1.4-0.9-1.9-0.4
2m
+11.4-0.6+12.0-0.9+12.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

DCM Shriram Fine Chemicals posted Q1 FY27 (Jun 2026) results: standalone revenue from operations fell about 8 percent YoY to Rs 90.18 crore (vs Rs 97.92 crore), while net profit dropped 42 percent to Rs 2.42 crore (vs Rs 4.13 crore). MD and CEO Akshay Dhar resigned; Rudra Shriram, son of Chairman Alok B Shriram, named new MD for 5 years. Rakesh Malhotra joins as Independent Director. Prior period figures restated due to composite scheme effective December 2025.

Likely market impact

Weak quarter with profit down 42% YoY. Promoter-family MD transition adds near-term focus question, though continuity of group leadership is maintained.